Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2018-09-26 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于签署募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a convertible bond issuance by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the amount raised, the opening of special accounts for the funds, the supervisory roles of the sponsor and banks, and the terms of the agreement. There are no financial statements, earnings data, or management discussion of results. The document is a formal announcement about the management and supervision of fundraising proceeds, not a financial report or audit. It fits the category of Capital/Financing Update (CAP) as it relates to fundraising activities and capital management.
2018-09-26 Chinese
关于全资子公司完成工商变更登记的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the completion of industrial and commercial registration changes for its wholly-owned subsidiary Zhejiang Jingyuetang Pharmaceutical Co., Ltd. It references a previous announcement about using raised funds to increase capital in the subsidiary. The content focuses on corporate registration updates and capital increase details, not on financial results, audit, or management changes. The document is short (902 characters) and serves as a formal public notice of a corporate event rather than a detailed report or financial filing. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2018-09-21 Chinese
关于召开华通转债2018年第一次债券持有人会议的通知
Capital/Financing Update Classification · 95% confidence The document is a notice for a bondholders' meeting regarding convertible bonds issued by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes details about the meeting time, location, voting procedures, and agenda items such as increasing the pledge guarantor for the convertible bonds. The document is a formal announcement to bondholders about the meeting and does not contain financial statements, audit results, or detailed financial analysis. It is not an annual report, interim report, earnings release, or any other financial report. It is also not a proxy solicitation or voting results announcement but a meeting notice. Therefore, the document fits best into the category of a Capital/Financing Update (CAP) because it relates to bondholder meetings and financing matters concerning convertible bonds.
2018-09-14 Chinese
2018年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening and procedures of the 2018 first extraordinary general meeting (临时股东大会) of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the legality of the meeting's call, attendance, voting procedures, and results. It does not contain financial statements or management discussion but focuses on the legality and procedural correctness of the shareholder meeting. This type of document is typically associated with the Declaration of Voting Results & Voting Rights Announcements category, as it confirms the voting results and legality of the shareholder meeting proceedings. The document length is 3409 characters, which is relatively short but contains substantive content about the meeting and voting results, not just an announcement of a report. Therefore, the best fit is DVA (Declaration of Voting Results & Voting Rights Announcements).
2018-09-07 Chinese
2018年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2018 First Extraordinary General Meeting of Shareholders" of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. There is no financial data, no detailed report, or presentation of company performance. The document is an official announcement of the voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2071 characters), consistent with an announcement rather than a full report.
2018-09-07 Chinese
独立董事关于公司第三届董事会第十六次会议相关事项的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent opinion from the independent directors of Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the company's 2018 half-year fundraising fund storage and usage, external guarantees, and related party fund occupation. It references regulatory compliance with the China Securities Regulatory Commission and Shenzhen Stock Exchange rules. The document is short (715 characters) and provides an opinion on specific matters related to the company's interim period but does not contain full financial statements or comprehensive financial data. It is not a full interim report but rather an audit-related opinion or certification on specific compliance matters. Therefore, it fits best under Audit Report / Information (AR). H1 2018
2018-08-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.